Clinical Trials Directory

Trials / Completed

CompletedNCT06254339

Effects of OAGB and DJB-SG on 10-year and Lifetime Risks of MACE

The Effect of MBS on Outcomes and Reduction of the 10-year and Lifetime Risks of MACE: Analysis of 224 Patients Undergoing OAGB and DJB-SG During a 7-year Period.

Status
Completed
Phase
Study type
Observational
Enrollment
830 (actual)
Sponsor
National Defense Medical Center, Taiwan · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Metabolic bariatric surgery (MBS) has demonstrated its efficacy in achieving sustainable weight loss and alleviating associated comorbidities. The primary objective of our investigation is to assess the long-term impact and sustainability of weight loss, the remission of T2D as well as risk prediction of cardiovascular events following MBS concerning one-anastomosis gastric bypass (OAGB) and duodenojejunal bypass with sleeve gastrectomy (DJB-SG).

Detailed description

Metabolic bariatric surgery (MBS) offers enduring weight reduction and alleviation of obesity-related comorbidities, including dyslipidemia, type 2 diabetes (T2D), hypertension (HTN), and major adverse cardiovascular events (MACE). Long-term data on one anastomosis gastric bypass (OAGB) and duodenal-jejunal bypass with sleeve gastrectomy (DJB-SG) is lacking, necessitating this investigation. In this multicenter prospectively-collected retrospective observational study, patients with complete follow-up data at various intervals up to 3 years after surgery were included in the final analysis. The study's primary focus was to evaluate the long-term safety, efficacy, and durability of OAGB and DJB-SG in promoting weight loss and T2D remission. Additionally, changes in 10-year and lifetime risks of MACE before and 3-year after surgery were assessed using the Taiwan MACE risk prediction model and the China-PAR project model based on Taiwan national electronic health records and a large Chinese participant dataset, respectively. Hypothesis: This study contributes to providing valuable information in terms of the impacts of OAGB and DJB-SG on patients with obesity and associated diseases.

Conditions

Interventions

TypeNameDescription
PROCEDUREOAGBusing OAGB procedure as metabolic bariatric surgery
PROCEDUREDJB-SGusing DJB-SG procedure as metabolic bariatric surgery

Timeline

Start date
2011-01-01
Primary completion
2017-12-31
Completion
2023-06-30
First posted
2024-02-12
Last updated
2024-02-13

Source: ClinicalTrials.gov record NCT06254339. Inclusion in this directory is not an endorsement.